AR007638A1 - Preparados farmaceuticos que contienen creatina, utilizacion de dicho preparado y procedimiento para su elaboracion - Google Patents
Preparados farmaceuticos que contienen creatina, utilizacion de dicho preparado y procedimiento para su elaboracionInfo
- Publication number
- AR007638A1 AR007638A1 ARP970102838A ARP970102838A AR007638A1 AR 007638 A1 AR007638 A1 AR 007638A1 AR P970102838 A ARP970102838 A AR P970102838A AR P970102838 A ARP970102838 A AR P970102838A AR 007638 A1 AR007638 A1 AR 007638A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- pharmaceutical preparations
- preparations
- magnesium
- operations
- Prior art date
Links
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 4
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 3
- 229960003624 creatine Drugs 0.000 title abstract 2
- 239000006046 creatine Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 2
- 229910052749 magnesium Inorganic materials 0.000 abstract 2
- 239000011777 magnesium Substances 0.000 abstract 2
- 238000011084 recovery Methods 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 206010014561 Emphysema Diseases 0.000 abstract 1
- 208000001640 Fibromyalgia Diseases 0.000 abstract 1
- 208000002720 Malnutrition Diseases 0.000 abstract 1
- 208000021642 Muscular disease Diseases 0.000 abstract 1
- 201000009623 Myopathy Diseases 0.000 abstract 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 abstract 1
- 230000001612 cachectic effect Effects 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- 230000001071 malnutrition Effects 0.000 abstract 1
- 235000000824 malnutrition Nutrition 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 230000004220 muscle function Effects 0.000 abstract 1
- 208000015380 nutritional deficiency disease Diseases 0.000 abstract 1
- 230000002787 reinforcement Effects 0.000 abstract 1
- 201000004193 respiratory failure Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000004904 shortening Methods 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Preparados farmacéuticos que comprenden creatina. La misma en combinación con por lo menos una sal de un metal del grupo calcio, magnesio, maganeso ozinc es adecuada para la recuperación terapéutica de la masa muscular con la correspondiente mejora de las funciones musculares y de la capacidad deresistencia, acortamiento de la fase de recuperación después de un esfuerzo físico, como también para la modificación positiva de la relación masa magra /masa grasa. Igualmente estos preparadosfarmacéuticos son adecuados como preparados de refuerzo o para el tratamiento previo en operaciones del corazón,en el tratamiento de trastornos cardíacos, insuficiencia respiratorias, enfisemas, después de operaciones o en general parala eliminación de estadosde carencia y para la substitución en tiempos de mayores requerimientos como también en desnutrición, en fibromialgias o en diversos tipos de miopatías yestados caquecticos. También, se refiere a utilización de dichos preparados y a un procedimiento para la elaboración de los mismos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96110445 | 1996-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR007638A1 true AR007638A1 (es) | 1999-11-10 |
Family
ID=8222944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970102838A AR007638A1 (es) | 1996-06-28 | 1997-06-27 | Preparados farmaceuticos que contienen creatina, utilizacion de dicho preparado y procedimiento para su elaboracion |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR007638A1 (es) |
| AU (1) | AU3086897A (es) |
| WO (1) | WO1998000148A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1298420B1 (it) * | 1996-11-19 | 2000-01-05 | Monsanto It Spa | Uso della creatina nell'insufficienza cardio-respiratoria |
| JP3384539B2 (ja) * | 1997-09-05 | 2003-03-10 | 義之 内田 | 喘息治療剤 |
| EP1002532A1 (en) * | 1998-11-19 | 2000-05-24 | K.U. Leuven Research & Development | Prevention of aging effects and treatment of muscle atrophy |
| US8613959B2 (en) | 2009-02-10 | 2013-12-24 | Fhg Corporation | Dietary supplements containing extracts of Nelumbo and processes of using same |
| WO2017106687A1 (en) * | 2015-12-18 | 2017-06-22 | Lonza Inc. | Method and composition for increasing muscle protein synthesis and/or functional strength in mammals as well as method of producing a composition |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3221827A1 (de) * | 1982-06-09 | 1983-12-15 | DSO Pharmachim, Sofija | Biostimulierendes mittel |
| GB9215746D0 (en) * | 1992-07-24 | 1992-09-09 | Hultman Eric | A method of increasing creatine supply depot |
-
1997
- 1997-06-25 AU AU30868/97A patent/AU3086897A/en not_active Withdrawn
- 1997-06-25 WO PCT/CH1997/000252 patent/WO1998000148A1/de not_active Ceased
- 1997-06-27 AR ARP970102838A patent/AR007638A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998000148A1 (de) | 1998-01-08 |
| AU3086897A (en) | 1998-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Glossmann et al. | Calcium channels | |
| Varghese et al. | Spinal cord injuries following electrical accidents | |
| DE69434431D1 (de) | Methoden zur behandlung von muskelerkrankungen und muskelstörungen | |
| PA8453501A1 (es) | Derivados dipeptidicos | |
| AR008444A1 (es) | Empleo de antagonistas de leptina para el tratamiento de la resistencia a la insulina en diabetes del tipo ii | |
| BR0107705A (pt) | Uso de uma alìquota de sangue modificado em um paciente para tratamento de falência cardìaca congestiva | |
| Khedr et al. | Peripheral neuropathy in burn patients | |
| AR007638A1 (es) | Preparados farmaceuticos que contienen creatina, utilizacion de dicho preparado y procedimiento para su elaboracion | |
| Elofsson et al. | Catecholamine-containing nerve fibres in the hind-gut of the crayfish Astacus astacus L.(Crustacea, Decapoda) | |
| Haim et al. | Muscle cramps associated with vincristine therapy | |
| ES2196456T3 (es) | Compuestos ciclicos de cinco eslabones en el anillo condensado que llevan un grupo sulfonamida, su uso como medicamentos y composiciones farmaceuticas que los contienen. | |
| Grobbelaar et al. | Flexor pollicis longus tendon injuries in children | |
| HUP9903688A2 (hu) | Olanzapin alkalmazása az autizmus kezelésére szolgáló gyógyszerkészítmény előállítására | |
| Fara | Escape from tension induced by noradrenaline or electrical stimulation in isolated mesenteric arteries | |
| PA8568001A1 (es) | Composicion farmaceutica | |
| Fieve et al. | Rubidium: overview and clinical perspectives | |
| Karaki et al. | Palytoxin‐induced contraction and release of endogenous noradrenaline in rat tail artery | |
| Devanand et al. | Electroconvulsive therapy-induced hypomania is uncommon | |
| Chance | THE EFFECTS OF TWO RANGES OF FLUORESCENT LIGHTING SPECTRA ON HUMAN PHYSICAL PERFORMANCE. | |
| ATE126437T1 (de) | Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf. | |
| Ojewole et al. | P-1: Possible mechanisms of antihypertensive effect of garlic: Evidence from mammalian experimental models | |
| SU1685447A1 (ru) | Способ лечени микоза стоп | |
| Barker et al. | Recovery of function following hip resurfacing: a randomised controlled trial comparing a tailored versus standard physiotherapy rehabilitation programme | |
| Zhao et al. | An 88-year-old man with syncope and an alternating axis | |
| Cassina et al. | SCS effectiveness in patients affected by peripheral chronic arterial disease: our 5 years experience |